Exciting News! Saama Wins “AI-based Life Sciences Solution of the Year” Award in 2026 AI Breakthrough Awards
Read the latest news from Saama.
Getting Ready for AI in Clinical Trials This recap of a presentation by Malaikannan Sankarasubbu, VP of AI Research at Saama; Aamir Jaka, Saama’s VP
Bringing Treatments to Patients Faster by Democratizing ClinTech The Silicon Review talked with Suresh Katta, Saama’s Chairman Emeritus, about using artificial intelligence (AI) and other
Saama Appoints Scott Rogers as Company’s Chief Financial Officer Scott brings a unique combination of financial and clinical fused with growth experience to Saama New
CAMPBELL, CA – (November 19, 2021) – Saama Technologies, LLC. (“Saama”) today announced the appointment of six individuals to its Board of Directors. Saama board
Carlyle and co-investors including Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund (“Merck GHI”), McKesson Ventures, Northpond Ventures, Pfizer Ventures, and Population Health Partners
Private Equity Powerhouse Leads Group of Investors Bullish on AI Leading business publication Forbes broke the news of Saama’s $430 million funding deal with a
Saama’s customized cloud strategy aligned with AWS Saama Smart Applications for fast-tracked clinical innovation supported by AWS Saama ensures faster, safer clinical development via AWS
Digital Transformation Included a Focus on Data Quality This article from Analytics Insight explains how Pfizer’s willingness to embrace digital transformation and artificial intelligence (AI)
Learning Lessons from Abbott’s Global Pandemic Defense Coalition In response to an article in Modern Healthcare on the Abbott Pandemic Defense Coalition, Nekzad Shroff, Saama’s
